Clinical Trials in Ohio

Showing 6721-6740 of 20,938 trials

Active Not RecruitingNA32 miles

Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair

NCT05142618

This study aims to evaluate the potential role of physical therapy in improving outcomes after ventral hernia repair.

Ventral HerniaHerniaHerniorrhaphy+3 more

Ohio State University138 participantsStarted Apr 2022

Columbus, Ohio, United States

TERMINATEDPhase 132 miles

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)

NCT04771897

This study will evaluate the safety of BXQ-350 and determine the maximum tolerated dose (MTD) in children with newly diagnosed DIPG or DMG. All patients will receive BXQ-350 by intravenous (IV) infusion and radiation therapy. The study is divided into two parts: Part 1 will enroll patients at increasing dose levels of BXQ-350 in order to determine the MTD. Part 2 will enroll patients requiring a biopsy in order to assess BXQ-350 concentrations in the biopsied tumor.

Diffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3 K27M-Mutant

Bexion Pharmaceuticals, Inc.10 participantsStarted May 2021

Aurora, Colorado, United States • Cincinnati, Ohio, United States • Columbus, Ohio, United States

Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)

Find Trials by Condition in Ohio

A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

CYPRESS Efficacy and Safety Study Extension

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)

Opioid-Free Anesthetic for Tonsillectomy

Oral ONC201 in Adult Recurrent Glioblastoma

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Global Fenestrated Anaconda Clinical STudy